NFKB1 and breast carcinoma: Collectively, our results provide evidence for an oncogenic PKCζ–NFκB-p65 signaling node that suppresses E-cadherin and ZO-1 expression in breast cancer cells and might promote EMT to facilitate in situ to invasive transition of breast cancers.